EVALUATE THE CONCENTRATION OF SERUM CFDNA AND INTEGRITY AS A NON-INVASIVE MARKER TO DISTINGUISH BETWEEN MALIGNANT AND BENIGN BREAST LESION. RJDNMD. 2024;31(1):366-389. Accessed May 18, 2024. https://jrdiabet.ro/index.php/RJDNMD/article/view/304